There are 2789 resources available
886P - Circulating tumor DNA kinetics in recurrent/metastatic head & neck squamous cell cancer (R/M HNSCC) patients
Presenter: Kirsty Taylor
Session: ePoster Display
887P - Final results and biomarker analysis from a phase I dose-expansion (part II) study of ISU104 (barecetamab; a novel anti-ErbB3) monotherapy or in combination with cetuximab (CET), in patients (pts) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
Presenter: Sung-Bae Kim
Session: ePoster Display
811P - The stem cell markers expression in the primary ovarian cancer tissue
Presenter: Sneghanna Gening
Session: ePoster Display
812P - Demographics and survival outcomes in patients with advanced or recurrent endometrial cancer (EC) following platinum-based doublet (PBD) in the English real-world (RW) setting
Presenter: Craig Knott
Session: ePoster Display
813P - Efficacy and safety of trastuzumab deruxtecan in HER2-expressing uterine carcinosarcoma (STATICE trial, NCCH1615): A multicenter, phase II clinical trial
Presenter: Kosei Hasegawa
Session: ePoster Display
814P - Prevalence of HER2 overexpression and amplification in uterine cervical cancer: A systematic review and a meta-analysis
Presenter: Boris Itkin
Session: ePoster Display
815TiP - ENGOT/GYN1/NCRI: ATR inhibitor in combination with olaparib in gynaecological cancers with ARID1A loss or no loss (ATARI)
Presenter: Susana Banerjee
Session: ePoster Display
897P - Genomic alterations in smokers with oropharyngeal squamous cell cancer (OSCC) determined by targeted next generation sequencing
Presenter: Panagiota Economopoulou
Session: ePoster Display